These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26555665)

  • 21. In vitro bioactivity and degradation behavior of silica xerogels intended as controlled release materials.
    Radin S; Falaize S; Lee MH; Ducheyne P
    Biomaterials; 2002 Aug; 23(15):3113-22. PubMed ID: 12102182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sol-gel-processed sintered silica xerogel as a carrier in controlled drug delivery.
    Kortesuo P; Ahola M; Karlsson S; Kangasniemi I; Kiesvaara J; Yli-Urpo A
    J Biomed Mater Res; 1999 Feb; 44(2):162-7. PubMed ID: 10397917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-assembling methoxypoly(ethylene glycol)-b-poly(carbonate-co-L-lactide) block copolymers for drug delivery.
    Danquah M; Fujiwara T; Mahato RI
    Biomaterials; 2010 Mar; 31(8):2358-70. PubMed ID: 20018369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silicon-polymer hybrid materials for drug delivery.
    McInnes SJ; Voelcker NH
    Future Med Chem; 2009 Sep; 1(6):1051-74. PubMed ID: 21425994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro evaluation of biodegradable epsilon-caprolactone-co-D, L-lactide/silica xerogel composites containing toremifene citrate.
    Ahola M; Rich J; Kortesuo P; Kiesvaara J; Seppälä J; Yli-Urpo A
    Int J Pharm; 1999 Apr; 181(2):181-91. PubMed ID: 10370214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-vitro controlled release of doxorubicin from silica xerogels.
    Prokopowicz M
    J Pharm Pharmacol; 2007 Oct; 59(10):1365-73. PubMed ID: 17910811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New generation poly(ε-caprolactone)/gel-derived bioactive glass composites for bone tissue engineering: Part I. Material properties.
    Dziadek M; Menaszek E; Zagrajczuk B; Pawlik J; Cholewa-Kowalska K
    Mater Sci Eng C Mater Biol Appl; 2015 Nov; 56():9-21. PubMed ID: 26249560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro tobramycin elution analysis from a novel beta-tricalcium phosphate-silicate-xerogel biodegradable drug-delivery system.
    DiCicco M; Goldfinger A; Guirand F; Abdullah A; Jansen SA
    J Biomed Mater Res B Appl Biomater; 2004 Jul; 70(1):1-20. PubMed ID: 15199578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The sol-gel prepared SiO2-CaO-P2O5 composites doped with Metronidazole for application in local delivery systems.
    Czarnobaj K; Sawicki W
    Pharm Dev Technol; 2012; 17(6):697-704. PubMed ID: 21480825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The controlled release of drugs from emulsified, sol gel processed silica microspheres.
    Radin S; Chen T; Ducheyne P
    Biomaterials; 2009 Feb; 30(5):850-8. PubMed ID: 19010531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of acrylate-based block copolymers prepared by atom transfer radical polymerization as matrices for paclitaxel delivery from coronary stents.
    Richard RE; Schwarz M; Ranade S; Chan AK; Matyjaszewski K; Sumerlin B
    Biomacromolecules; 2005; 6(6):3410-8. PubMed ID: 16283773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analgesic properties of calcium phosphate apatite loaded with bupivacaine on postoperative pain.
    Verron E; Gauthier O; Janvier P; Le Guen H; Holopherne D; Cavagna R; Bouler JM
    J Biomed Mater Res B Appl Biomater; 2010 Jul; 94(1):89-96. PubMed ID: 20524182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thermoresponsive polymeric gel as an on-demand transdermal drug delivery system for pain management.
    Indulekha S; Arunkumar P; Bahadur D; Srivastava R
    Mater Sci Eng C Mater Biol Appl; 2016 May; 62():113-22. PubMed ID: 26952404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sol-gel processing of anti-inflammatory entrapment in silica, release kinetics, and bioactivity.
    Catauro M; Melisi D; Curcio A; Rimoli MG
    J Biomed Mater Res A; 2008 Dec; 87(4):843-9. PubMed ID: 18200553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silica-polyethylene glycol matrix synthesis by sol-gel method and evaluation for diclofenac diethyloammonium release.
    Prokopowicz M
    Drug Deliv; 2007 Mar; 14(3):129-38. PubMed ID: 17454032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended duration local anesthetic agent in a rat paw model.
    Ickowicz DE; Golovanevski L; Domb AJ; Weiniger CF
    Int J Pharm; 2014 Jul; 468(1-2):152-7. PubMed ID: 24726301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled release of lidocaine hydrochloride from the surfactant-doped hybrid xerogels.
    Wu Z; Joo H; Lee TG; Lee K
    J Control Release; 2005 Jun; 104(3):497-505. PubMed ID: 15911049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual-responsive supramolecular hydrogels from water-soluble PEG-grafted copolymers and cyclodextrin.
    Ren L; He L; Sun T; Dong X; Chen Y; Huang J; Wang C
    Macromol Biosci; 2009 Sep; 9(9):902-10. PubMed ID: 19544291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo efficacy of an intratumorally injected in situ-forming doxorubicin/poly(ethylene glycol)-b-polycaprolactone diblock copolymer.
    Kang YM; Kim GH; Kim JI; Kim DY; Lee BN; Yoon SM; Kim JH; Kim MS
    Biomaterials; 2011 Jul; 32(20):4556-64. PubMed ID: 21440935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biodegradable poly(ether-ester) multiblock copolymers for controlled release applications.
    van Dijkhuizen-Radersma R; Roosma JR; Kaim P; Métairie S; Péters FL; de Wijn J; Zijlstra PG; de Groot K; Bezemer JM
    J Biomed Mater Res A; 2003 Dec; 67(4):1294-304. PubMed ID: 14624516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.